Central and peripheral interactions between endocannabinoids and steroids, and implications for drug dependence

Life Sciences

Volumn 77, Issue 14, 2005, Pages 1559-1568

  Maccarrone, Mauro ^a,b  

^a UNIVERSITY OF TERAMO   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Anandamide; Estrogen; Glucocorticoid; Glutamate; Progesterone; Promoter; Receptor; Retrograde signaling

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CARRIER PROTEIN; ENDOCANNABINOID; FATTY ACID AMIDASE; GLUTAMIC ACID; ISOENZYME; LIPID; N ACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D; SEROTONIN; STEROID; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DRUG DEPENDENCE; ESTROGEN DEFICIENCY; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; GENE EXPRESSION; HEART PROTECTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOLECULAR INTERACTION; NEGATIVE FEEDBACK; NONHUMAN; PROMOTER REGION; REGULATORY MECHANISM; STEROID METABOLISM; STEROID RELEASE; T LYMPHOCYTE; THALAMUS MIDLINE NUCLEUS;

BLOOD CELLS; ENDOCANNABINOIDS; GLUTAMIC ACID; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NERVOUS SYSTEM; PITUITARY-ADRENAL SYSTEM; SIGNAL TRANSDUCTION; STEROIDS; SUBSTANCE-RELATED DISORDERS;

EID: 23044454149     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.006     Document Type: Conference Paper

References (50)

1. J. Bar, J. Lahav, M. Hod, Z. Ben-Rafael, I. Weinberger, and J. Brosens Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women Thrombosis and Haemostasis 84 2000 695 700
2. B.S. Basavarajappa, and B.L. Hungund Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2002 287 299
3. M.H. Bracey, M.A. Hanson, K.R. Masuda, R.C. Stevens, and B.F. Cravatt Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling Science 298 2002 1793 1796
4. M.E. Carroll, W.J. Lynch, M.E. Roth, A.D. Morgan, and K.P. Cosgrove Sex and estrogen influence drug abuse Trends in Pharmacological Sciences 25 2004 273 279
5. I. Casserly, and E. Topol Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins Lancet 363 2004 1139 1146
6. B.J. Cravatt, and A.H. Lichtman Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system Current Opinion in Chemical Biology 7 2003 469 475
7. L. De Petrocellis, T. Bisogno, M. Maccarrone, J.B. Davis, A. Finazzi-Agrò, and V. Di Marzo The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism Journal of Biological Chemistry 276 2001 12856 12863
8. L. De Petrocellis, M.G. Cascio, and V. Di Marzo The endocannabinoid system: a general view and latest additions British Journal of Pharmacology 141 2004 765 774
9. W.A. Devane, L. Hannus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
10. S. Di, R. Malcher-Lopes, K.C. Halmos, and J.G. Tasker Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism Journal of Neuroscience 23 2003 4850 4857
11. V. Di Marzo, L. De Petrocellis, F. Fezza, A. Ligresti, and T. Bisogno Anandamide receptors Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2002 377 391
12. E. Falkenstein, H.C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple actions of steroid hormones-a focus on rapid, nongenomic effects Pharmacological Reviews 52 2000 513 556
13. C. Fimiani, H. Magazine, I.D. Welters, T.V. Bilfinger, F. Salsano, E. Tonnesen, and G.B. Stefano Antagonism of LPS and IFN-gamma induced iNOS expression in human atrial endothelia by morphine, anandamide, and estrogen Acta Pharmacologica Sinica 21 2000 405 409
14. E. Fride Endocannabinoids in the central nervous system-an overview Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2002 221 233
15. G.L. Gerdeman, J.G. Partridge, C.R. Lupica, and D.M. Lovinger It could be habit forming: drugs of abuse and striatal synaptic plasticity Trends in Neurosciences 26 2003 184 192
16. S. Gonzalez, T. Bisogno, T. Wenger, J. Manzanares, A. Milone, F. Berrendero, V. Di Marzo, J.A. Ramos, and J.J. Fernandez-Ruiz Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland Biochemical and Biophysical Research Communications 270 2000 260 266
17. M. Guzman Cannabinoids: potential anticancer agents Nature Reviews. Cancer 3 2003 745 755
18. C.J. Hillard, and A. Jarrahian Cellular accumulation of anandamide: consensus and controversy British Journal of Pharmacology 140 2003 802 808
19. B.L. Hungund, I. Szakall, A. Adam, B.S. Basavarajappa, and C. Vadasz Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens Journal of Neurochemistry 84 2003 698 704
20. L. Iversen Cannabis and the brain Brain 126 2003 1252 1270
21. S.E. Jordt, and D. Julius Molecular basis for species-specific sensitivity to "hot" chili peppers Cell 108 2002 421 430
22. Y.S. Jung, T.S. Cho, C.H. Moon, B. Lee, S.M. Lee, and H.S. Shin Systemically administered capsazepine prevents the capsaicin-induced functional desensitization and loss of substance P-like immunoreactivity (SP-LI) in guinea-pig bronchi Life Sciences 64 1999 173 177
23. T.C. Kirkham, C.M. Williams, F. Fezza, and V. Di Marzo Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol British Journal of Pharmacology 136 2002 550 557
24. G. Kunos, Z. Jarai, S. Batkai, S.K. Goparaju, E.J. Ishac, J. Liu, L. Wang, and J.A. Wagner Endocannabinoids as cardiovascular modulators Chemistry and Physics of Lipids 108 2000 159 168
25. A.H. Lichtman, S.A. Varvel, and B.R. Martin Endocannabinoids in cognition and dependence Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2002 269 285
26. M. Maccarrone, and A. Finazzi-Agrò Endocannabinoids and their actions Vitamins and Hormones 65 2002 225 255
27. M. Maccarrone, M. De Felici, M. Bari, F. Klinger, G. Siracusa, and A. Finazzi-Agrò Down-regulation of anandamide hydrolase in mouse uterus by sex hormones European Journal of Biochemistry 267 2000 2991 2997
28. M. Maccarrone, M. Bari, N. Battista, and A. Finazzi-Agrò Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation Blood 100 2002 4040 4048
29. M. Maccarrone, M. Bari, M. Di Rienzo, A. Finazzi-Agrò, and A. Rossi Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin Journal of Biological Chemistry 278 2003 32726 32732
30. 9-tetrahydrocannabinol modulation of sexual receptivity in female rats Proceedings of the National Academy of Sciences of the United States of America 98 2001 1249 1254
31. R. Mechoulam Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2002 93 99
32. R. Mechoulam, and L. Parker Cannabis and alcohol-a close friendship Trends in Pharmacological Sciences 24 2003 266 268
33. M.E. Mendelsohn, and R.H. Karas The protective effects of estrogen on the cardiovascular system New England Journal of Medicine 340 1999 1801 1811
34. Y. Okamoto, J. Morishita, K. Tsuboi, T. Tonai, and N. Ueda Molecular characterization of a phospholipase D generating anandamide and Its congeners Journal of Biological Chemistry 279 2004 5298 5305
35. D. Parolaro, P. Massi, T. Rubino, and E. Monti Endocannabinoids in the immune system and cancer Prostaglandins, Leukotrienes and Essential Fatty Acids 66 2002 319 332
36. R.G. Pertwee Pharmacology of cannabinoid receptor ligands Current Medicinal Chemistry 6 1999 635 664
37. D. Piomelli The molecular logic of endocannabinoid signalling Nature Reviews. Neuroscience 4 2003 873 884
38. R.A. Puffenbarger, O. Kapulina, J.M. Howell, and D.G. Deutsch Characterization of the 5′-sequence of the mouse fatty acid amide hydrolase Neuroscience Letters 314 2001 21 24
39. R. Rimondini, C. Arlinde, W. Sommer, and M. Heilig Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol FASEB Journal 16 2002 27 35
40. B.S. Sachais Platelet-endothelial interactions in atherosclerosis Current Atherosclerosis Reports 3 2001 412 416
41. C. Scorticati, C. Mohn, A. De Laurentiis, P. Vissio, J. Fernandez Solari, A. Seilicovich, S.M. McCann, and V. Rettori The effect of anandamide on prolactin secretion is modulated by estrogen Proceedings of the National Academy of Sciences of the United States of America 100 2003 2134 2139
42. K.E. Sheppard Corticosteroid receptors, 11 beta-hydroxysteroid dehydrogenase, and the heart Vitamins and Hormones 66 2003 77 112
43. G.B. Stefano, V. Prevot, J.C. Beauvillain, P. Cadet, C. Fimiani, I. Welters, G.L. Fricchione, C. Breton, P. Lassalle, M. Salzet, and T.V. Bilfinger Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia Circulation 101 2000 1594 1597
44. B. Stoffel-Wagner Neurosteroid biosynthesis in the human brain and its clinical implications Annals of the New York Academy of Sciences 1007 2003 64 78
45. M. Wan, B.F. Cravatt, H.Z. Ring, X. Zhang, and U. Francke Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation Genomics 54 1998 408 414
46. J. Weidenfeld, S. Feldman, and R. Mechoulam Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat Neuroendocrinology 59 1994 110 112
47. T. Wenger, C. Ledent, V. Csernus, and I. Gerendai The central cannabinoid receptor inactivation suppresses endocrine reproductive functions Biochemical and Biophysical Research Communications 284 2001 363 368
48. 1 cannabinoid receptor knockout mice Neuroendocrinology 78 2003 294 300
49. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682
50. B.N. Zenor, G.D. Weesner, and P.V. Malven Endocrine and other responses to acute administration of cannabinoid compounds to non-stressed male calves Life Sciences 65 1999 125 133